Russell Investments Group Ltd. lessened its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 45.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 361,891 shares of the company’s stock after selling 300,460 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.08% of GE HealthCare Technologies worth $23,705,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of the stock. Ritholtz Wealth Management bought a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $1,285,000. Joel Isaacson & Co. LLC bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $207,000. Jacobi Capital Management LLC bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $52,000. Jefferies Financial Group Inc. raised its position in shares of GE HealthCare Technologies by 56.1% during the 3rd quarter. Jefferies Financial Group Inc. now owns 371,013 shares of the company’s stock valued at $24,253,000 after acquiring an additional 133,360 shares in the last quarter. Finally, First Command Advisory Services Inc. raised its position in shares of GE HealthCare Technologies by 226.1% during the 3rd quarter. First Command Advisory Services Inc. now owns 1,784 shares of the company’s stock valued at $117,000 after acquiring an additional 1,237 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on GEHC shares. BTIG Research raised their price objective on GE HealthCare Technologies from $75.00 to $83.00 and gave the stock a “buy” rating in a research note on Wednesday, October 28th. Argus boosted their target price on shares of GE HealthCare Technologies from $85.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, November 11th. Weiss Ratings raised shares of GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, October 6th. Barclays increased their target price on shares of GE HealthCare Technologies from $85.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, October 29th. Finally, Evercore restated an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $82.17.
Read Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Trading Down 1.4%
Shares of NASDAQ GEHC opened at $81.84 on Wednesday. The company has a market cap of $37.00 billion, a price-to-earnings ratio of 17.27, a price-to-earnings-growth ratio of 2.09 and a beta of 0.65. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. The stock’s 50 day simple moving average is $71.13 and its 200 day simple moving average is $70.15.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. The business had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.35 billion. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.07 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 5.02 EPS for the current year.
GE HealthCare Technologies Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Friday, October 23rd were given a $0.04 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, October 23rd. GE HealthCare Technologies’s dividend payout ratio is 3.38%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
